| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |